DK1610770T3 - Anvendelse af en IBAT-inhibitor til behandling eller profylakse af forstoppelse - Google Patents
Anvendelse af en IBAT-inhibitor til behandling eller profylakse af forstoppelseInfo
- Publication number
- DK1610770T3 DK1610770T3 DK04725081T DK04725081T DK1610770T3 DK 1610770 T3 DK1610770 T3 DK 1610770T3 DK 04725081 T DK04725081 T DK 04725081T DK 04725081 T DK04725081 T DK 04725081T DK 1610770 T3 DK1610770 T3 DK 1610770T3
- Authority
- DK
- Denmark
- Prior art keywords
- constipation
- prophylaxis
- treatment
- ibat inhibitor
- ibat
- Prior art date
Links
- 206010010774 Constipation Diseases 0.000 title 1
- 229940125922 IBAT inhibitor Drugs 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307918.3A GB0307918D0 (en) | 2003-04-05 | 2003-04-05 | Therapeutic use |
| PCT/GB2004/001396 WO2004089350A1 (en) | 2003-04-05 | 2004-04-01 | Use of an ibat inhibitor for the treatment of prophylaxis of constipation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1610770T3 true DK1610770T3 (da) | 2008-05-13 |
Family
ID=9956272
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07023058.6T DK1894564T3 (da) | 2003-04-05 | 2004-04-01 | Anvendelse af en IBAT inhibitor til behandling eller profylakse af konstipation |
| DK04725081T DK1610770T3 (da) | 2003-04-05 | 2004-04-01 | Anvendelse af en IBAT-inhibitor til behandling eller profylakse af forstoppelse |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07023058.6T DK1894564T3 (da) | 2003-04-05 | 2004-04-01 | Anvendelse af en IBAT inhibitor til behandling eller profylakse af konstipation |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US7514421B2 (da) |
| EP (2) | EP1610770B1 (da) |
| JP (2) | JP4870552B2 (da) |
| KR (1) | KR101321577B1 (da) |
| CN (1) | CN100366241C (da) |
| AR (1) | AR043985A1 (da) |
| AT (2) | ATE387194T1 (da) |
| AU (1) | AU2004228731B2 (da) |
| BR (1) | BRPI0408858A (da) |
| CA (1) | CA2520109C (da) |
| CO (1) | CO5640076A2 (da) |
| CY (2) | CY1107424T1 (da) |
| DE (1) | DE602004012079T2 (da) |
| DK (2) | DK1894564T3 (da) |
| ES (2) | ES2368350T3 (da) |
| GB (1) | GB0307918D0 (da) |
| IL (1) | IL170913A (da) |
| IS (1) | IS8113A (da) |
| MX (1) | MXPA05010706A (da) |
| MY (1) | MY137757A (da) |
| NO (1) | NO335140B1 (da) |
| NZ (1) | NZ542835A (da) |
| PL (2) | PL1610770T3 (da) |
| PT (2) | PT1610770E (da) |
| RU (2) | RU2342928C2 (da) |
| SA (1) | SA04250066B1 (da) |
| SI (2) | SI1610770T1 (da) |
| TW (1) | TWI338577B (da) |
| UA (1) | UA84141C2 (da) |
| UY (1) | UY28258A1 (da) |
| WO (1) | WO2004089350A1 (da) |
| ZA (1) | ZA200507996B (da) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
| GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
| GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| WO2003022286A1 (en) | 2001-09-08 | 2003-03-20 | Astrazeneca Ab | Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
| GB0304194D0 (en) * | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
| GB0307918D0 (en) * | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
| AR057828A1 (es) * | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica |
| JP5404429B2 (ja) * | 2007-03-08 | 2014-01-29 | アルビレオ・アクチボラグ | ２−置換３−フェニルプロピオン酸誘導体および炎症性腸疾患の治療におけるそれらの使用 |
| CN102316872B (zh) * | 2008-11-26 | 2016-12-21 | 萨蒂奥根制药公司 | 治疗肥胖症和糖尿病的胆汁酸再循环抑制剂 |
| EP3593802A3 (en) | 2010-05-26 | 2020-03-25 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| KR101890959B1 (ko) * | 2010-11-04 | 2018-08-22 | 알비레오 에이비 | 간질환 치료를 위한 ｉｂａｔ 억제제 |
| EA030839B1 (ru) | 2011-10-28 | 2018-10-31 | ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи | Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей |
| WO2013063526A1 (en) | 2011-10-28 | 2013-05-02 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease |
| CN105228615A (zh) | 2013-03-15 | 2016-01-06 | 鲁美纳医药公司 | 用于治疗巴雷特食管和胃食管返流疾病的胆汁酸再循环抑制剂 |
| JP2016514684A (ja) | 2013-03-15 | 2016-05-23 | ルメナ ファーマシューティカルズ エルエルシー | 原発性硬化性胆管炎および炎症性腸疾患の処置のための胆汁酸再循環阻害剤 |
| JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
| KR101420315B1 (ko) | 2014-03-19 | 2014-07-17 | 남봉길 | 약학적 액제 조성물 |
| CN106659726A (zh) * | 2014-06-25 | 2017-05-10 | Ea制药株式会社 | 固体制剂及其着色防止或着色减少方法 |
| CN106573033A (zh) * | 2014-06-25 | 2017-04-19 | Ea制药株式会社 | 固体制剂及其稳定化方法 |
| EP3012252A1 (en) | 2014-10-24 | 2016-04-27 | Ferring BV | Crystal modifications of elobixibat |
| RU2018105869A (ru) | 2015-08-17 | 2019-09-19 | Ферринг Б.В. | Жидкие составы, содержащие пикосульфат и цитрат магния |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| WO2018009761A1 (en) | 2016-07-08 | 2018-01-11 | Ferring B.V. | Stabilized liquid formulations containing picosulfate |
| HRP20231236T1 (hr) | 2017-06-20 | 2024-02-16 | Takeda Pharmaceutical Company Limited | Heterociklički spoj i njegova uporaba kao pozitivnog alosteričnog modulatora kolinergičkog muskarinskog m1 receptora |
| CA3071285A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | Cholestyramine granules, oral cholestyramine formulations and use thereof |
| US10428109B1 (en) | 2018-03-09 | 2019-10-01 | Elobix Ab | Process for the preparation of 1,5-benzothiazepine compounds |
| BR112020017353A2 (pt) | 2018-03-09 | 2020-12-15 | Elobix Ab | Processos para a preparação de um composto e de uma modificação de cristal iv de elobixibat. |
| CN112449637B (zh) | 2018-06-05 | 2024-03-19 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| SG11202012151XA (en) | 2018-06-20 | 2021-01-28 | Albireo Ab | Crystal modifications of odevixibat |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| MX2021008981A (es) | 2019-02-06 | 2021-09-08 | Albireo Ab | Compuestos de benzotiadiazepina y su uso como moduladores del acido biliar. |
| AU2020221834B2 (en) | 2019-02-12 | 2025-10-23 | Mirum Pharmaceuticals, Inc. | Genotype and dose-dependent response to an ASBTI in patients with bile salt export pump deficiency |
| JP7689076B2 (ja) | 2019-09-09 | 2025-06-05 | Ｅａファーマ株式会社 | １，５－ベンゾチアゼピン化合物を製造するための方法 |
| EP4069360B1 (en) | 2019-12-04 | 2024-01-03 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| JP7696898B2 (ja) | 2019-12-04 | 2025-06-23 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| CN114761080B (zh) | 2019-12-04 | 2024-07-23 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| CA3158184A1 (en) | 2019-12-04 | 2021-08-10 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| ES3002777T3 (en) | 2020-08-03 | 2025-03-07 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| EP4243831A1 (en) | 2020-11-12 | 2023-09-20 | Albireo AB | Odevixibat for treating progressive familial intrahepatic cholestasis (pfic) |
| EP4255565A1 (en) | 2020-12-04 | 2023-10-11 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
| TW202313579A (zh) | 2021-06-03 | 2023-04-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途 |
| WO2022166680A1 (zh) * | 2021-06-25 | 2022-08-11 | 苏州科睿思制药有限公司 | 奥德昔巴特的晶型及其制备方法和用途 |
| CN119053330A (zh) | 2022-04-22 | 2024-11-29 | 阿尔比里奥公司 | 皮下给药asbt抑制剂 |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4771072A (en) | 1985-01-10 | 1988-09-13 | Tanabe Seiyaku Co., Ltd. | Alkoxynaphthalene derivatives |
| JPS6310746A (ja) | 1986-07-01 | 1988-01-18 | Tanabe Seiyaku Co Ltd | ナフタレン誘導体 |
| US4900757A (en) | 1988-12-08 | 1990-02-13 | Merrell Dow Pharmaceuticals Inc. | Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane |
| DE3930696A1 (de) | 1989-09-14 | 1991-03-28 | Hoechst Ag | Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel |
| NZ240846A (en) | 1990-12-06 | 1994-04-27 | Hoechst Ag | Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions |
| ATE175954T1 (de) | 1991-10-17 | 1999-02-15 | Shionogi & Co | Verfahren zum herstellen von lignin-analoga und ausgangsprodukte dafür |
| NZ245503A (en) | 1991-12-20 | 1995-11-27 | Hoechst Ag | Polymers containing bile acids; pharmaceuticals and preparatory methods |
| JPH05186357A (ja) * | 1991-12-31 | 1993-07-27 | Shigeo Ochi | 飲食物消化分解産物吸収抑制手段 |
| GB9201180D0 (en) * | 1992-01-21 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
| GB9203347D0 (en) * | 1992-02-17 | 1992-04-01 | Wellcome Found | Hypolipidaemic compounds |
| DK0573848T3 (da) | 1992-06-12 | 1998-08-10 | Hoechst Ag | Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler |
| IL108634A0 (en) | 1993-02-15 | 1994-05-30 | Wellcome Found | Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them |
| ZA941003B (en) | 1993-02-15 | 1995-08-14 | Wellcome Found | Hypolipidaemic compounds |
| US5488134A (en) | 1993-04-16 | 1996-01-30 | Shionogi & Co., Ltd. | Preparation of compounds of lignan series |
| TW289021B (da) | 1993-05-08 | 1996-10-21 | Hoechst Ag | |
| TW289020B (da) | 1993-05-08 | 1996-10-21 | Hoechst Sktiengesellschaft | |
| EP0624593A3 (de) | 1993-05-08 | 1995-06-07 | Hoechst Ag | Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel. |
| ZA956647B (en) | 1994-08-10 | 1997-02-10 | Wellcome Found | Hypolipidaemic compounds. |
| US5994391A (en) | 1994-09-13 | 1999-11-30 | G.D. Searle And Company | Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| EP0781278B1 (en) | 1994-09-13 | 2001-03-14 | Monsanto Company | Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| GB9423172D0 (en) | 1994-11-17 | 1995-01-04 | Wellcom Foundation The Limited | Hypolipidemic benzothiazepines |
| EP0888333B1 (en) | 1996-03-11 | 2005-08-31 | G.D. Searle LLC | Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| JP2002508652A (ja) | 1996-08-23 | 2002-03-19 | ヒューマン ジノーム サイエンシーズ，インコーポレイテッド | 新規なヒト増殖因子 |
| JPH1072371A (ja) | 1996-08-28 | 1998-03-17 | Sankyo Co Ltd | 回腸型胆汁酸トランスポーター阻害剤 |
| GB9704208D0 (en) | 1997-02-28 | 1997-04-16 | Glaxo Group Ltd | Chemical compounds |
| JP2002500628A (ja) | 1997-03-11 | 2002-01-08 | ジー．ディー．サール アンド カンパニー | 回腸胆汁酸輸送阻害ベンゾチエピンおよびＨＭＧ Ｃｏ−Ａレダクターゼ阻害剤を用いた併用療法 |
| PT864582E (pt) | 1997-03-14 | 2003-10-31 | Aventis Pharma Gmbh | 1,4-benzotiazepina-1,1-dioxidos hipolipidemicos |
| DE19845402B4 (de) | 1998-10-02 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| PT869121E (pt) | 1997-04-04 | 2004-10-29 | Aventis Pharma Gmbh | Derivados de propanolamina hipolipidemicos |
| WO1998056757A1 (fr) | 1997-06-11 | 1998-12-17 | Sankyo Company, Limited | Derives de benzylamine |
| AUPO763197A0 (en) * | 1997-06-30 | 1997-07-24 | Sigma Pharmaceuticals Pty Ltd | Health supplement |
| ES2195428T3 (es) | 1997-12-19 | 2003-12-01 | Searle & Co | Metodo para preparar oxidos de tetrahidrobenzotiepina enriquecidos enantiometricamente. |
| GB9800428D0 (en) | 1998-01-10 | 1998-03-04 | Glaxo Group Ltd | Chemical compounds |
| DE19825804C2 (de) | 1998-06-10 | 2000-08-24 | Aventis Pharma Gmbh | 1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19845403B4 (de) | 1998-10-02 | 2005-02-10 | Aventis Pharma Deutschland Gmbh | Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| DE19845405C2 (de) | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
| DE19845406C2 (de) | 1998-10-02 | 2001-10-18 | Aventis Pharma Gmbh | Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| AU1684400A (en) | 1998-12-11 | 2000-07-03 | Sankyo Company Limited | Substituted benzylamines |
| BR9916484A (pt) | 1998-12-23 | 2002-01-22 | Searle Llc | Combinações de inibidores do transporte de ácido biliar ileal e de agentes sequestrantes de ácido biliar em indicações cardiovasculares |
| DE69911058T2 (de) | 1998-12-23 | 2004-06-03 | G.D. Searle Llc, Chicago | Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen |
| HUP0104593A3 (en) | 1998-12-23 | 2004-10-28 | G D Searle Llc Chicago | Combinations of benzothiepine ileal bile acid transport inhibitor and nicotinic acid derivatives for cardiovascular indications |
| HK1045114A1 (zh) | 1998-12-23 | 2002-11-15 | G‧D‧瑟尔有限公司 | 适用於心血管疾病的回肠胆汁酸转运抑制剂和贝酸衍生物的组合 |
| PT1140188E (pt) | 1998-12-23 | 2003-10-31 | Searle Llc | Combinacoes de inibidores do transporte de acidos biliares do ileo e de inibidores da proteina de transferencia de esteres de colesterilo para doencas cardiovasculares. |
| AU3694600A (en) | 1999-02-12 | 2000-08-29 | G.D. Searle Llc | Novel 1,2-benzothiazepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| DE19916108C1 (de) | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung |
| SE9901387D0 (sv) | 1999-04-19 | 1999-04-19 | Astra Ab | New pharmaceutical foromaulations |
| US6287609B1 (en) * | 1999-06-09 | 2001-09-11 | Wisconsin Alumni Research Foundation | Unfermented gel fraction from psyllium seed husks |
| CZ290178B6 (cs) | 1999-07-22 | 2002-06-12 | Sankyo Company Limited | Deriváty cyklobutenu |
| AU1302301A (en) | 1999-11-08 | 2001-06-06 | Sankyo Company Limited | Nitrogenous heterocycle derivatives |
| EP1259494A4 (en) | 2000-02-18 | 2004-09-15 | Merck & Co Inc | ARYLOXYACETIC ACIDS FOR DIABETES AND LIPID DISORDERS |
| SE0000772D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | Chemical compounds |
| WO2001068096A2 (en) | 2000-03-10 | 2001-09-20 | Pharmacia Corporation | Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders |
| AU2001240115A1 (en) | 2000-03-10 | 2001-09-24 | Pharmacia Corporation | Method for the preparation of tetrahydrobenzothiepines |
| US20020183307A1 (en) | 2000-07-26 | 2002-12-05 | Tremont Samuel J. | Novel 1,4-benzothiazephine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake |
| SE0003766D0 (sv) | 2000-10-18 | 2000-10-18 | Astrazeneca Ab | Novel formulation |
| EG26979A (en) * | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
| WO2002053548A1 (fr) | 2000-12-27 | 2002-07-11 | Banyu Pharmaceutical Co.,Ltd. | Derives de la benzothiazepine |
| US6506921B1 (en) * | 2001-06-29 | 2003-01-14 | Virginia Tech Intellectual Properties, Inc. | Amine compounds and curable compositions derived therefrom |
| GB0121337D0 (en) * | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
| GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| AR036873A1 (es) * | 2001-09-07 | 2004-10-13 | Euro Celtique Sa | Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento |
| GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| WO2003022286A1 (en) | 2001-09-08 | 2003-03-20 | Astrazeneca Ab | Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| GB0201850D0 (en) * | 2002-01-26 | 2002-03-13 | Astrazeneca Ab | Therapeutic treatment |
| GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
| GB0216321D0 (en) | 2002-07-13 | 2002-08-21 | Astrazeneca Ab | Therapeutic treatment |
| GB0304194D0 (en) | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
| GB0307918D0 (en) * | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
-
2003
- 2003-04-05 GB GBGB0307918.3A patent/GB0307918D0/en not_active Ceased
-
2004
- 2004-04-01 AT AT04725081T patent/ATE387194T1/de active
- 2004-04-01 EP EP04725081A patent/EP1610770B1/en not_active Expired - Lifetime
- 2004-04-01 SI SI200430662T patent/SI1610770T1/sl unknown
- 2004-04-01 PL PL04725081T patent/PL1610770T3/pl unknown
- 2004-04-01 BR BRPI0408858-1A patent/BRPI0408858A/pt not_active Application Discontinuation
- 2004-04-01 AT AT07023058T patent/ATE513550T1/de active
- 2004-04-01 JP JP2006506065A patent/JP4870552B2/ja not_active Expired - Lifetime
- 2004-04-01 DK DK07023058.6T patent/DK1894564T3/da active
- 2004-04-01 SI SI200431710T patent/SI1894564T1/sl unknown
- 2004-04-01 CN CNB200480009415XA patent/CN100366241C/zh not_active Expired - Lifetime
- 2004-04-01 WO PCT/GB2004/001396 patent/WO2004089350A1/en not_active Ceased
- 2004-04-01 EP EP07023058A patent/EP1894564B1/en not_active Expired - Lifetime
- 2004-04-01 PL PL07023058T patent/PL1894564T3/pl unknown
- 2004-04-01 PT PT04725081T patent/PT1610770E/pt unknown
- 2004-04-01 US US10/551,999 patent/US7514421B2/en not_active Expired - Lifetime
- 2004-04-01 RU RU2005128792/15A patent/RU2342928C2/ru active
- 2004-04-01 MX MXPA05010706A patent/MXPA05010706A/es active IP Right Grant
- 2004-04-01 ES ES07023058T patent/ES2368350T3/es not_active Expired - Lifetime
- 2004-04-01 UA UAA200508758A patent/UA84141C2/ru unknown
- 2004-04-01 AU AU2004228731A patent/AU2004228731B2/en not_active Ceased
- 2004-04-01 DK DK04725081T patent/DK1610770T3/da active
- 2004-04-01 NZ NZ542835A patent/NZ542835A/en not_active IP Right Cessation
- 2004-04-01 KR KR1020057018959A patent/KR101321577B1/ko not_active Expired - Lifetime
- 2004-04-01 ES ES04725081T patent/ES2299832T3/es not_active Expired - Lifetime
- 2004-04-01 DE DE602004012079T patent/DE602004012079T2/de not_active Expired - Lifetime
- 2004-04-01 CA CA2520109A patent/CA2520109C/en not_active Expired - Lifetime
- 2004-04-01 PT PT07023058T patent/PT1894564E/pt unknown
- 2004-04-02 MY MYPI20041236A patent/MY137757A/en unknown
- 2004-04-05 SA SA04250066A patent/SA04250066B1/ar unknown
- 2004-04-05 TW TW093109383A patent/TWI338577B/zh not_active IP Right Cessation
- 2004-04-05 UY UY28258A patent/UY28258A1/es not_active Application Discontinuation
- 2004-04-06 AR ARP040101159A patent/AR043985A1/es not_active Application Discontinuation
-
2005
- 2005-09-15 IL IL170913A patent/IL170913A/en unknown
- 2005-09-21 NO NO20054369A patent/NO335140B1/no unknown
- 2005-10-03 ZA ZA200507996A patent/ZA200507996B/xx unknown
- 2005-10-25 CO CO05108676A patent/CO5640076A2/es not_active Application Discontinuation
- 2005-11-01 IS IS8113A patent/IS8113A/is unknown
-
2008
- 2008-04-24 CY CY20081100461T patent/CY1107424T1/el unknown
- 2008-07-17 RU RU2008129204/15A patent/RU2482850C2/ru active
-
2011
- 2011-06-07 JP JP2011127175A patent/JP5421326B2/ja not_active Expired - Lifetime
- 2011-09-07 CY CY20111100862T patent/CY1111995T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1894564T3 (da) | Anvendelse af en IBAT inhibitor til behandling eller profylakse af konstipation | |
| DK2308507T3 (da) | Fremgangsmåder til behandling af præeklampsi | |
| EP1755661A4 (en) | USE OF GELSOLINE FOR THE TREATMENT OF INFECTIONS | |
| DK1427437T3 (da) | Oxyntomodulin til forebyggelse eller behandling af overvægt | |
| NO20071926L (no) | Anvendelse av en mTOR-inhibitor i behandling av uterint leioyom. | |
| DK3403657T3 (da) | Anvendelse af oligouronater til behandling af slimhyperviskositet | |
| DK1487828T3 (da) | Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme | |
| EP1495756A4 (en) | THERAPEUTIC AGENT FOR SEVERE SEPTIC STATE PREVENTION | |
| FI20021531A0 (fi) | Muurausmenetelmä | |
| DE60325855D1 (de) | Rifampicin zur Behandlung der Angiogenese | |
| DK3332789T3 (da) | Cladribinkur til behandling af multipel sklerose | |
| DK1496918T3 (da) | Anvendelse af natriummetaarsenit til behandling af tumorer | |
| EP1784181A4 (en) | VEGF Inhibition | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| IS7970A (is) | PDE4-hemlar til að meðhöndla eitlafrumuæxli | |
| EP1910272A4 (en) | Renin Inhibitors | |
| FI20040180L (fi) | Koostumus psoriasis-taudin hoitamiseksi | |
| FR2843451B1 (fr) | Fronde du type lance-pierres | |
| IS7963A (is) | Efnasambönd með hamlandi virkni gegn prólýlólígópeptíðasa | |
| DE60307471D1 (de) | Hemmung | |
| NO20022243D0 (no) | Fremgangsmåte for rörlegging | |
| NO20033160D0 (no) | Anordning for behandling av gravann | |
| DK1535612T3 (da) | Behandling af hyperurikæmi | |
| DK1519732T3 (da) | Anvendelse af inhibitorer af vasopeptidase til behandling af nefropati | |
| DE60326035D1 (de) | Dipyridodiazepinone als inhibitoren der reversen transkriptase |